📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.
Eris Lifesciences Ltd
Eris Lifesciences's GHG Emissions Data Preview
In 2025, Eris Lifesciences completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Eris Lifesciences has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2025 | 2024 | 2023 | 2022 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | 0000000 |
Verified Sources Behind Eris Lifesciences’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Eris Lifesciences’s data sources below and access millions more through our Disclosure Search.
Insights into Eris Lifesciences's Operational Emissions
In 2025, the total operational greenhouse gas (GHG) emissions ofEris Lifesciences amounted to9,039.63metric tons of CO2 equivalent.This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2024, the total operational greenhouse gas (GHG) emissions of Eris Lifesciencesdecreased by 8.87%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a
Eris Lifesciences's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Eris Lifesciences's Scope 1 emissions?
In 2025, the total Scope 1 emissions of Eris Lifesciences were 1,082.74 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a
Compared to the previous year(2024), Eris Lifesciences's Scope 1 emissions decreased by 13.04%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a
What are Eris Lifesciences's Scope 2 emissions?
In 2025, Eris Lifesciences reported Scope 2 greenhouse gas (GHG) emissions of 7,956.89 tCOâ‚‚e without specifying the calculation method.a
Has Eris Lifesciences reduced its Scope 2 emissions over time?
Compared to the previous year(2024), Eris Lifesciences's Scope 2 emissions(Unspecified Calculation Method) have remained relatively stable, indicating that Eris Lifesciences's emissions have plateaued with no significant change in its energy consumption footprint.a
What methodology does Eris Lifesciences use for Scope 2 reporting?
In 2025, Eris Lifesciences reported its Scope 2 emissions using an unspecified methodology.a
Eris Lifesciences's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Eris Lifesciences’s GHG Emissions Intensity Compared to Industry Peers
In 2025, Eris Lifesciences reported Scope 1 greenhouse gas (GHG) emissions of 1,082.74 tCOâ‚‚e and total revenues of USD 337 millions. This translates into an emissions intensity of 3.21 tCOâ‚‚e per millions USD.a
Eris Lifesciences's Scope 1 Emissions Intensity Compared to Peers
How does Eris Lifesciences's GHG emissions intensity compare to its peers?
In 2025, Eris Lifesciences reported a Scope 1 emissions intensity of 3.21 tCOâ‚‚e per millions USD. Compared to the peer group median of 24.05, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a
Where does Eris Lifesciences rank on GHG emissions intensity within its industry?
In 2025, Eris Lifesciences ranked 2 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCOâ‚‚e per millions USD).a
This places Eris Lifesciences among the top performers, with one of the lowest emissions intensities relative to peers.a